Overview

Pharmacokinetics of Two Formulations of Entecavir

Status:
Completed

Trial end date:
2016-02-01

Target enrollment:

Participant gender:

Summary

A Randomized, Parallel, Single-Dose Study to Evaluate the Pharmacokinetics of a Test Formulation of Entigin Film Coated Tablet 0.5mg (Entecavir 0.5 mg), Compared to an Equivalent Dose of a Reference Drug Product (Baraclude 0.5mg Tablets) in Healthy

Phase:

Phase 4

Details

Lead Sponsor:

Yung Shin Pharm. Ind. Co., Ltd.

Collaborator:

Taichung Veterans General Hospital

Treatments:

Entecavir